Abstract 3721: MTORC1/2 and HDAC1/2 inhibition as therapy for colorectal cancer with PIK3CA mutation

Authors: Autumn M. Olson, Rebecca A. DeStefanis, Alyssa K. DeZeeuw, Susan N. Payne, Cheri A. Pasch, Linda Clipson, Dustin A. Deming

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-3721

Source: Full article

---

Abstract

Abstract